Purpose
To assess the impact of varying magnetic resonance imaging (MRI) scanner parameters on the extraction of algorithmic features in breast MRI radiomics studies.
Methods
In this retrospective study, breast imaging data for 272 patients were analyzed with magnetic resonance (MR) images. From the MR images, we assembled and implemented 529 algorithmic features of breast tumors and fibrograndular tissue (FGT). We divided the features into 10 groups based on the type of data used for the feature extraction and the nature of the extracted information. Three scanner parameters were considered: scanner manufacturer, scanner magnetic field strength, and slice thickness. We assessed the impact of each of the scanner parameters on each of the feature by testing whether the feature values are systematically diverse for different values of these scanner parameters. A two-sample t-test has been used to establish whether the impact of a scanner parameter on values of a feature is significant and receiver operating characteristics have been used for to establish the extent of that effect.
Results
On average, higher proportion (69% FGT versus 20% tumor) of FGT related features were affected by the three scanner parameters. Of all feature groups and scanner parameters, the feature group related to the variation in FGT enhancement was found to be the most sensitive to the scanner manufacturer (AUC = 0.81 ± 0.14).
Conclusions
Features involving calculations from FGT are particularly sensitive to the scanner parameters.
The estimation of sparse hierarchical components reflecting patterns of the brain's functional connectivity from rsfMRI data can contribute to our understanding of the brain's functional organization, and can lead to biomarkers of diseases. However, inter-scanner variations and other confounding factors pose a challenge to the robust and reproducible estimation of functionally-interpretable brain networks, and especially to reproducible biomarkers. Moreover, the brain is believed to be organized hierarchically, and hence single-scale decompositions miss this hierarchy. The paper aims to use current advancements in adversarial learning to estimate interpretable hierarchical patterns in the human brain using rsfMRI data, which are robust to "adversarial effects" such as interscanner variations. We write the estimation problem as a minimization problem and solve it using alternating updates. Extensive experiments on simulation and a real-world dataset show high reproducibility of the components compared to other well-known methods.
Resting-state fMRI has been shown to provide surrogate biomarkers for the analysis of various diseases. In addition, fMRI data helps in understanding the brain's functional working during resting state and task-induced activity. To improve the statistical power of biomarkers and the understanding mechanism of the brain, pooling of multi-center studies has become increasingly popular. But pooling the data from multiple sites introduces variations due to hardware, software, and environment. In this paper, we look at the estimation problem of hierarchical Sparsity Connectivity Patterns (hSCPs) in fMRI data acquired on multiple sites. We introduce a simple yet effective matrix factorization based formulation to reduce site-related effects while preserving biologically relevant variations. We leverage adversarial learning in the unsupervised regime to improve the reproducibility of the components. Experiments on simulated datasets display that the proposed method can estimate components with improved accuracy and reproducibility. We also demonstrate the improved reproducibility of the components while preserving age-related variation on a real dataset compiled from multiple sites.Preprint. Under review.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.